Literature DB >> 7075407

Circulating immune complexes in Crohn's disease. Their characterization and interrelationship with components of the complement system.

E R Richens, C M Thorp, P W Bland, N D Hall.   

Abstract

Of the sera from 55 patients with Crohn's disease, 37% showed evidence of anticomplementary activity, C3 and C4 levels were significantly increased in these patients compared with control subjects, although total hemolytic complement levels were normal. C3 inactivation products were demonstrated in 32.9% of serum and plasma samples from 51 patients with CD. This was taken to be evidence of in vivo activation of C3 and the complement system. Activation of the C' system was thought to be caused by circulating immune complexes since evidence of anticomplementary activity could be correlated with incidence of C3 activation. Gel filtration studies carried out on 15 serum samples (13 patients) showing anticomplementary activity showed this activity to be confined to two fractions of molecular weight range greater than 10(6) and 2 x 10(5) - 10(6) daltons. IgG and IgA were present in both these fractions. As the molecular weights of IgG and IgA are lower than the molecular weight range of these fractions, it is possible that the immune complexes were composed of IgG and possibly IgA complexed with antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075407     DOI: 10.1007/bf01311706

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

2.  Persistence of serum complement in sera of patients with ulcerative colitis.

Authors:  W R THAYER; H M SPIRO
Journal:  J Lab Clin Med       Date:  1963-07

3.  C3 metabolism in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

4.  Evidence of cytotoxicity in ulcerative colitis from immunofluorescent staining of the rectal mucosa.

Authors:  J Ballard; M Shiner
Journal:  Lancet       Date:  1974-05-25       Impact factor: 79.321

5.  Circulating immune complexes in inflammatory bowel disease.

Authors:  D P Jewell; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Proceedings: Serum complement components C3 and C4 in inflammatory bowel disease.

Authors:  M Ward; M A Eastwood
Journal:  Gut       Date:  1974-10       Impact factor: 23.059

8.  Humoral immune system in inflammatory bowel disease: I. Complement levels.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

9.  Humoral immune system activity in inflammatory bowel disease.

Authors:  P Teisberg; E Gjone
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

10.  Circulating immune complexes in ulcerative colitis.--II. Correlation with serum protein concentrations and complement conversion products.

Authors:  H Nielsen; P H Petersen; S E Svehag
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

View more
  2 in total

1.  Immune complexes in ulcerative colitis.

Authors:  R P Learmonth; E Pihl; W R Johnson
Journal:  Dig Dis Sci       Date:  1984-04       Impact factor: 3.199

Review 2.  Circadian Clock and Complement Immune System-Complementary Control of Physiology and Pathology?

Authors:  Pooja Shivshankar; Baharan Fekry; Kristin Eckel-Mahan; Rick A Wetsel
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.